Day Zero Diagnostics gathers $8.6 mln Series A

Boston-based Day Zero Diagnostics Inc, an infectious disease diagnostic company, has closed $8.6 million in Series A funding. Triventures led the round with participation from other investors that included Sands Capital Ventures and Golden Seeds.

Source: Press Release